BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2014
View Archived Issues
Development of non-viral minicircle DNA vectors for phenylketonuria gene therapy
Read More
Auigene Discovery Technologies and UM Pharmauji report DHODH inhibitors
Read More
AAK1 inhibitors disclosed in recent BMS patent
Read More
Long-term treatment with fingolimod sustains low rates of brain volume loss in LONGTERMS trial
Read More
Immunotope licenses CaPtivate's nanoparticle technology for T-cell vaccines
Read More
OncoCyte to use Abcodia's serum bank to validate its PanC-Dx cancer diagnostic
Read More
BARDA contract supports InDevR's development of FluChip-8G influenza diagnostic
Read More
MGB Biopharma raises funding for phase I trial of novel antibacterial MGB-BP-3
Read More
ASP-2397, a natural product with potent fungicidal activity
Read More
TapImmune reports interim data from phase I trial of folate receptor alpha antigens
Read More
FDA assigns orphan drug designation to various cancer therapies under development
Read More
Novel potent inhibitors of histone demethylase KDM1A for epigenetic-related cancer therapy
Read More
Oncolytics reports progression-free survival data from trial of Reolysin in pancreatic cancer
Read More
In vitro and in vivo bone anabolic effects of P2X7 receptor blocker AFC-5261
Read More
Alnylam Pharmaceuticals describes siRNA for treating pre-eclampsia
Read More
Empagliflozin/linagliptin FDC shows superior efficacy to individual components
Read More
Akashi Therapeutics acquires worldwide rights to GsMTx-4
Read More
Concert Pharmaceuticals begins phase I trial of CTP-730
Read More
Sun Pharma and Merck & Co. form licensing agreement for tildrakizumab
Read More
Prezcobix launched in Canada for HIV
Read More
Otsuka Pharmaceutical receives approval for BCR-ABL mRNA measurement kit
Read More
Parion Sciences receives award from Cystic Fibrosis Foundation Therapeutics
Read More
CTI BioPharma and Servier to develop and commercialize Pixuvri
Read More
NicOx to acquire French ophthalmic company Doliage
Read More
BioBlast Pharma reports data from several studies of Cabaletta
Read More
FDA places clinical hold on phase IIb study of Flexion's FX-006 for knee osteoarthritis
Read More